VITL insider sale notice: 21,442 shares via Morgan Stanley on 08/18/2025

Rhea-AI Filing Summary

Form 144 for Vital Farms, Inc. (VITL) shows a proposed sale of 21,442 common shares valued at $1,023,855.50 to be executed on 08/18/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The filing states these shares were acquired the same day by exercise of stock options from the issuer and paid in cash. The filer also reported recent 10b5-1 sales on 08/15/2025 of 12,005 shares generating $571,346.76. The filing includes an assurance that the signer does not possess undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider option exercise and planned sale; size is modest relative to outstanding shares.

The filing documents a same-day option exercise and proposed sale of 21,442 shares for $1,023,855.50, with prior 10b5-1 sales of 12,005 shares for $571,346.76. Against the reported outstanding share count of 44,685,980, the proposed sale represents a de minimis ownership change and appears to be an orderly disposition through a broker. There is no disclosure here of material operational or financial changes.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure consistent with Rule 144 and 10b5-1 practices.

The notice provides required details: acquisition date, nature of acquisition (option exercise), payment method (cash), broker identity, and recent 10b5-1 sales. The signer affirms absence of undisclosed material information, aligning with certification expectations. No governance red flags or unexpected departures are disclosed in this form.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21442	1023855.50	44685980	08/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/18/2025	Exercise of Stock Options	Issuer			21442	08/18/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for KATHRYN MCKEON 3601 South Congress Avenue Suite C100 Austin TX 78704	Common	08/15/2025	12005	571346.76

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does the Form 144 for VITL report?

The form reports a proposed sale of 21,442 common shares of Vital Farms, valued at $1,023,855.50, to be sold on 08/18/2025 on NASDAQ.

How were the shares acquired before the sale?

The shares were acquired on 08/18/2025 by exercise of stock options from the issuer, with payment made in cash.

Who is the broker handling the proposed sale?

The filing lists Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004) as the broker.

Were there any recent insider sales disclosed in the filing?

Yes. The filing discloses 10b5-1 sales by Kathryn McKeon on 08/15/2025 of 12,005 shares for gross proceeds of $571,346.76.

Does the filer assert possession of any undisclosed material information?

By signing, the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.